Newborn Dried Blood-Spot Screening

Newborn Screening is a public health activity used for early identification of infants affected by certain genetic, metabolic, hormonal and/or functional conditions. Screening detects disorders in newborns that, if left untreated, can cause serious illness, disability and even death. Currently, the U. S. Health and Human Services recommends screening for 31 heritable disorders and genetic diseases performed through dried blood-spot testing, including SCID.